In the BioHarmony Drug Report Database

"Preview" Icon

Choriogonadotropin alfa

Ovidrel, Ovitrelle (choriogonadotropin alfa) is a protein pharmaceutical. Choriogonadotropin alfa was first approved as Ovidrel on 2000-09-20. It is used to treat cryptorchidism, female infertility, and hypogonadism in the USA. It has been approved in Europe to treat anovulation, assisted reproductive techniques, and female infertility.

 

Trade Name

 

Ovitrelle
 

Common Name

 

choriogonadotropin alfa
 

ChEMBL ID

 

CHEMBL1201464
 

Indication

 

anovulation, assisted reproductive techniques, cryptorchidism, female infertility, hypogonadism
 

Drug Class

 

Tricyclic compounds; atropine derivatives

Image (chem structure or protein)

Choriogonadotropin alfa structure rendering